Publication Information

{'id': 'https://openalex.org/W1840538016', 'doi': None, 'title': 'Clinical outcomes of patients with rheumatoid arthritis after switching from infliximab to etanercept.', 'display_name': 'Clinical outcomes of patients with rheumatoid arthritis after switching from infliximab to etanercept.', 'publication_year': 2004, 'publication_date': '2004-12-01', 'ids': {'openalex': 'https://openalex.org/W1840538016', 'mag': '1840538016', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/15570634'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/15570634', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['pubmed'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5030150540', 'display_name': 'Boulos Haraoui', 'orcid': 'https://orcid.org/0000-0002-9077-2201'}, 'institutions': [{'id': 'https://openalex.org/I4210107362', 'display_name': 'Hôpital Notre-Dame', 'ror': 'https://ror.org/01w7qz648', 'country_code': 'CA', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210107362', 'https://openalex.org/I4210142730']}, {'id': 'https://openalex.org/I4210142730', 'display_name': 'Centre Hospitalier de l’Université de Montréal', 'ror': 'https://ror.org/0410a8y51', 'country_code': 'CA', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210142730']}], 'countries': ['CA'], 'is_corresponding': False, 'raw_author_name': 'Boulos Haraoui', 'raw_affiliation_strings': ["Centre Hospitalier de l'Université de Montréal, Hôpital Notre-Dame, 1560 Sherbrooke East, Montréal, Quebec H2L 4M1, Canada. [email protected]"], 'affiliations': [{'raw_affiliation_string': "Centre Hospitalier de l'Université de Montréal, Hôpital Notre-Dame, 1560 Sherbrooke East, Montréal, Quebec H2L 4M1, Canada. [email protected]", 'institution_ids': ['https://openalex.org/I4210107362', 'https://openalex.org/I4210142730']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5080646462', 'display_name': 'Edward Keystone', 'orcid': 'https://orcid.org/0000-0001-6606-0071'}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Edward C Keystone', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5028238808', 'display_name': 'J. Carter Thorne', 'orcid': 'https://orcid.org/0000-0002-1721-190X'}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'J Carter Thorne', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5023213876', 'display_name': 'Janet Pope', 'orcid': 'https://orcid.org/0000-0003-1479-5302'}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Janet E Pope', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5103332274', 'display_name': 'Isaac Chen', 'orcid': 'https://orcid.org/0000-0003-4117-7956'}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Isaac Chen', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5084209325', 'display_name': 'Charles Asare', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Charles G Asare', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5103404398', 'display_name': 'Jonathan A. Leff', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Jonathan A Leff', 'raw_affiliation_strings': [], 'affiliations': []}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 2, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 6.828, 'has_fulltext': False, 'cited_by_count': 104, 'citation_normalized_percentile': {'value': 0.837245, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 96, 'max': 97}, 'biblio': {'volume': '31', 'issue': '12', 'first_page': '2356', 'last_page': '9'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10200', 'display_name': 'Rheumatoid Arthritis Research and Therapies', 'score': 0.9988, 'subfield': {'id': 'https://openalex.org/subfields/2745', 'display_name': 'Rheumatology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10200', 'display_name': 'Rheumatoid Arthritis Research and Therapies', 'score': 0.9988, 'subfield': {'id': 'https://openalex.org/subfields/2745', 'display_name': 'Rheumatology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11016', 'display_name': 'Monoclonal and Polyclonal Antibodies Research', 'score': 0.9985, 'subfield': {'id': 'https://openalex.org/subfields/2741', 'display_name': 'Radiology, Nuclear Medicine and Imaging'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11157', 'display_name': 'Chronic Lymphocytic Leukemia Research', 'score': 0.9976, 'subfield': {'id': 'https://openalex.org/subfields/2716', 'display_name': 'Genetics'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [], 'concepts': [{'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.97847223}, {'id': 'https://openalex.org/C2777226972', 'wikidata': 'https://www.wikidata.org/wiki/Q415343', 'display_name': 'Etanercept', 'level': 3, 'score': 0.94859886}, {'id': 'https://openalex.org/C2777138892', 'wikidata': 'https://www.wikidata.org/wiki/Q415264', 'display_name': 'Infliximab', 'level': 3, 'score': 0.9220753}, {'id': 'https://openalex.org/C2777575956', 'wikidata': 'https://www.wikidata.org/wiki/Q187255', 'display_name': 'Rheumatoid arthritis', 'level': 2, 'score': 0.8085476}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.71173584}, {'id': 'https://openalex.org/C197934379', 'wikidata': 'https://www.wikidata.org/wiki/Q2047938', 'display_name': 'Adverse effect', 'level': 2, 'score': 0.67258376}, {'id': 'https://openalex.org/C198451711', 'wikidata': 'https://www.wikidata.org/wiki/Q327657', 'display_name': 'Rheumatology', 'level': 2, 'score': 0.62023264}, {'id': 'https://openalex.org/C2777077863', 'wikidata': 'https://www.wikidata.org/wiki/Q170990', 'display_name': 'Arthritis', 'level': 2, 'score': 0.4344039}, {'id': 'https://openalex.org/C141071460', 'wikidata': 'https://www.wikidata.org/wiki/Q40821', 'display_name': 'Surgery', 'level': 1, 'score': 0.43250808}, {'id': 'https://openalex.org/C17991360', 'wikidata': 'https://www.wikidata.org/wiki/Q21173843', 'display_name': 'Tumor necrosis factor alpha', 'level': 2, 'score': 0.2579527}], 'mesh': [{'descriptor_ui': 'D001172', 'descriptor_name': 'Arthritis, Rheumatoid', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': True}, {'descriptor_ui': 'D007074', 'descriptor_name': 'Immunoglobulin G', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D018124', 'descriptor_name': 'Receptors, Tumor Necrosis Factor', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D000328', 'descriptor_name': 'Adult', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000368', 'descriptor_name': 'Aged', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000911', 'descriptor_name': 'Antibodies, Monoclonal', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000911', 'descriptor_name': 'Antibodies, Monoclonal', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': False}, {'descriptor_ui': 'D001172', 'descriptor_name': 'Arthritis, Rheumatoid', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D001172', 'descriptor_name': 'Arthritis, Rheumatoid', 'qualifier_ui': 'Q000175', 'qualifier_name': 'diagnosis', 'is_major_topic': False}, {'descriptor_ui': 'D004305', 'descriptor_name': 'Dose-Response Relationship, Drug', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004334', 'descriptor_name': 'Drug Administration Schedule', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000068800', 'descriptor_name': 'Etanercept', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D005260', 'descriptor_name': 'Female', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D005500', 'descriptor_name': 'Follow-Up Studies', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D007074', 'descriptor_name': 'Immunoglobulin G', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000069285', 'descriptor_name': 'Infliximab', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D007279', 'descriptor_name': 'Injections, Subcutaneous', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008297', 'descriptor_name': 'Male', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008875', 'descriptor_name': 'Middle Aged', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D010147', 'descriptor_name': 'Pain Measurement', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D011446', 'descriptor_name': 'Prospective Studies', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D016059', 'descriptor_name': 'Range of Motion, Articular', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D016059', 'descriptor_name': 'Range of Motion, Articular', 'qualifier_ui': 'Q000502', 'qualifier_name': 'physiology', 'is_major_topic': False}, {'descriptor_ui': 'D018124', 'descriptor_name': 'Receptors, Tumor Necrosis Factor', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D018570', 'descriptor_name': 'Risk Assessment', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D012720', 'descriptor_name': 'Severity of Illness Index', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D016037', 'descriptor_name': 'Single-Blind Method', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D016896', 'descriptor_name': 'Treatment Outcome', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/15570634', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'display_name': 'Good health and well-being', 'score': 0.8, 'id': 'https://metadata.un.org/sdg/3'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W2913960658', 'https://openalex.org/W2474189839', 'https://openalex.org/W2467737217', 'https://openalex.org/W2416981671', 'https://openalex.org/W2411569365', 'https://openalex.org/W2140231842', 'https://openalex.org/W2095585495', 'https://openalex.org/W2086963921', 'https://openalex.org/W2030855147', 'https://openalex.org/W1840538016'], 'abstract_inverted_index': {'To': [0], 'assess': [1], 'the': [2, 69, 95, 169, 181], 'efficacy': [3], 'and': [4, 82, 86, 88, 111, 161, 183, 203], 'monitor': [5], 'serious': [6, 89, 175], 'adverse': [7, 90, 176], 'events': [8, 91, 177], 'in': [9, 35, 133, 141, 155], 'patients': [10, 21, 54, 97, 125, 209], 'with': [11, 22, 29, 57], 'rheumatoid': [12], 'arthritis': [13], '(RA)': [14], 'switching': [15], 'treatment': [16, 28, 56, 205], 'from': [17], 'infliximab': [18, 30, 105], 'to': [19, 33, 45, 216], 'etanercept.Adult': [20], 'active': [23], 'RA': [24], 'who': [25], 'were': [26, 31, 78, 92, 98, 145, 178], 'discontinuing': [27], 'eligible': [32], 'enroll': [34], 'this': [36], 'prospective,': [37], '12-week,': [38], 'open': [39], 'label,': [40], 'single-arm,': [41], 'observational': [42], 'study.': [43], 'Four': [44], '10': [46], 'weeks': [47, 115], 'after': [48], 'their': [49], 'last': [50], 'infusion': [51], 'of': [52, 63, 72, 101, 107, 109, 116, 123, 164, 168, 188, 190], 'infliximab,': [53, 212], 'began': [55], 'etanercept': [58, 117], '(twice': [59], 'weekly': [60], 'subcutaneous': [61], 'injections': [62], '25': [64], 'mg).': [65], 'Clinical': [66], 'assessments': [67], 'using': [68], 'American': [70], 'College': [71], 'Rheumatology': [73], '(ACR)': [74], 'criteria': [75, 135, 171], 'for': [76, 207], 'improvement': [77, 132], 'performed': [79], 'at': [80, 83, 128], 'baseline': [81], 'Weeks': [84], '6': [85], '12,': [87], 'monitored': [93], 'throughout': [94], 'study.Twenty-five': [96], 'enrolled,': [99], '18': [100], 'whom': [102], 'had': [103, 172, 218], 'discontinued': [104, 186], 'because': [106, 187], 'lack': [108, 189], 'efficacy,': [110], '22': [112, 124], 'completed': [113], '12': [114, 120], 'treatment.': [118], 'After': [119], 'weeks,': [121], '14': [122], '(64%)': [126], 'achieved': [127], 'least': [129], 'a': [130, 192, 200, 213], '20%': [131], 'ACR': [134, 170], '(ACR20),': [136], '13': [137], '(59%)': [138], 'experienced': [139], 'improvements': [140], 'physical': [142], 'function': [143], 'that': [144], 'considered': [146], 'clinically': [147], 'important': [148], '(>': [149], 'or': [150], '=': [151], '0.22': [152], 'point': [153], 'decrease': [154], 'overall': [156], 'Health': [157], 'Assessment': [158], 'Questionnaire': [159], 'score),': [160], 'mean': [162], 'values': [163], 'all': [165], 'individual': [166], 'components': [167], 'improved.': [173], 'No': [174], 'reported': [179], 'during': [180], 'study': [182], 'no': [184], 'patient': [185], 'efficacy.Etanercept,': [191], 'soluble': [193], 'tumor': [194], 'necrosis': [195], 'factor': [196], '(TNF)': [197], 'receptor,': [198], 'provided': [199], 'well': [201], 'tolerated': [202], 'effective': [204], 'option': [206], 'some': [208], 'even': [210], 'when': [211], 'monoclonal': [214], 'antibody': [215], 'TNF,': [217], 'been': [219], 'ineffective.': [220]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W1840538016', 'counts_by_year': [{'year': 2021, 'cited_by_count': 1}, {'year': 2020, 'cited_by_count': 1}, {'year': 2019, 'cited_by_count': 1}, {'year': 2017, 'cited_by_count': 4}, {'year': 2016, 'cited_by_count': 4}, {'year': 2015, 'cited_by_count': 4}, {'year': 2014, 'cited_by_count': 10}, {'year': 2013, 'cited_by_count': 1}, {'year': 2012, 'cited_by_count': 4}], 'updated_date': '2024-12-14T09:09:46.979641', 'created_date': '2016-06-24'}